Equities

Kawamoto Corp

3604:TYO

Kawamoto Corp

Actions
Health CareMedical Equipment and Services
  • Price (JPY)786.00
  • Today's Change-2.00 / -0.25%
  • Shares traded5.30k
  • 1 Year change-7.53%
  • Beta-1.4079
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments1,5041,5301,132
Total Receivables, Net9,5559,3189,092
Total Inventory2,6942,9202,384
Prepaid expenses------
Other current assets, total836836868
Total current assets14,58814,60413,476
Property, plant & equipment, net3,1993,1282,017
Goodwill, net216238258
Intangibles, net449456287
Long term investments537472479
Note receivable - long term5.149.93--
Other long term assets401375406
Total assets19,54919,51017,156
LIABILITIES
Accounts payable4,0083,7893,981
Accrued expenses148174177
Notes payable/short-term debt2,7202,5002,144
Current portion long-term debt/capital leases8091,247877
Other current liabilities, total1,0001,0731,043
Total current liabilities8,6858,7838,222
Total long term debt2,4322,4652,222
Total debt5,9616,2125,243
Deferred income tax12011360
Minority interest66766159
Other liabilities, total561841687
Total liabilities12,46512,86311,249
SHAREHOLDERS EQUITY
Common stock883883883
Additional paid-in capital1,1481,1481,148
Retained earnings (accumulated deficit)4,4494,1403,474
Treasury stock - common(74)(74)(74)
Unrealized gain (loss)224181188
Other equity, total453369287
Total equity7,0846,6475,907
Total liabilities & shareholders' equity19,54919,51017,156
Total common shares outstanding5.805.805.80
Treasury shares - common primary issue0.200.200.20
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.